pre-IPO PHARMA

COMPANY OVERVIEW

Nurix, Inc. is a leader in discovering and developing a new class of drugs that work by modulating the protein regulation machinery of the cell.


LOCATION

  • San Francisco, CA, USA

  • THERAPEUTIC AREAS

  • Oncology

  • WEBSITE

    https://www.nurixtx.com


    CAREER WEBSITE

    https://www.nurix-inc.com/careers/


    SOCIAL MEDIA


    INVESTORS

    the-column-group third-rock-ventures


    PRESS RELEASES


    Jun 19, 2019

    Gilead and Nurix Establish Strategic Collaboration to Develop Novel Therapies for Cancer and Other Diseases


    Dec 6, 2016

    Nurix Appoints Robert Tjian, Ph.D. of The Column Group to its Board of Directors


    May 3, 2016

    Nurix Strengthens Executive Leadership Team


    May 3, 2016

    Nurix Announces New Appointments to Its Board of Directors


    Sep 16, 2015

    Celgene and Nurix Announce Collaboration Targeting Protein Homeostasis for Next-Generation Therapies in Oncology, Inflammation and Immunology


    For More Press Releases


    Google Analytics Alternative